Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Dr Karen Mustian - Wilmot Cancer Institute, Rochester, USA
Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment ( Dr Karen Mustian - Wilmot Cancer Institute, Rochester, USA )
31 May 2026

Daraxonrasib plus chemotherapy shows promising first-line activity in RAS-mutant metastatic pancreatic cancer

Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA
Daraxonrasib plus chemotherapy shows promising first-line activity in RAS-mutant metastatic pancreatic cancer ( Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA )
27 Apr 2026

Tumour-selective oncolytic adenovirus LOAd703 with chemo shows immune activation and promising responses in pancreatic cancer

Dr Angelica Loskog - Uppsala University, Uppsala, Sweden
Tumour-selective oncolytic adenovirus LOAd703 with chemo shows immune activation and promising responses in pancreatic cancer ( Dr Angelica Loskog -  Uppsala University, Uppsala, Sweden )
24 Apr 2026

Oncolytic adenovirus VCN-01 plus chemo shows promising survival benefit in metastatic pancreatic cancer

Dr Manuel Hidalgo - NYU Langone Health, New York, USA
Oncolytic adenovirus VCN-01 plus chemo shows promising survival benefit in metastatic pancreatic cancer ( Dr Manuel Hidalgo - NYU Langone Health, New York, USA )
24 Apr 2026

Using lived experience of pancreatic cancer to build faith-based support

Olayinka Sowemimo–Coker - Pancreatic cancer survivor and Founder of DChanger
Using lived experience of pancreatic cancer to build faith-based support ( Olayinka Sowemimo–Coker - Pancreatic cancer survivor and Founder of DChanger )
27 Jan 2026

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong
Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma ( Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )
15 Jan 2026

Talquetamab plus teclistamab shows promise in true extramedullary multiple myeloma

Dr Shahzad Raza - Cleveland Clinic, Cleveland, USA
Talquetamab plus teclistamab shows promise in true extramedullary multiple myeloma ( Dr Shahzad Raza - Cleveland Clinic, Cleveland, USA )
17 Dec 2025

Precision approaches to treating HPB cancers

Dr Milind Javle - The University of Texas MD Anderson Cancer Center Houston, Texas, EE. UU
Precision approaches to treating HPB cancers ( Dr Milind Javle - The University of Texas MD Anderson Cancer Center Houston, Texas, EE. UU )
7 Nov 2025

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection

Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA
MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection ( Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA )
19 Oct 2025

The hidden biology of addiction and cancer

Prof Raphael Cuomo - UC San Diego School of Medicine, San Diego, USA
The hidden biology of addiction and cancer ( Prof Raphael Cuomo - UC San Diego School of Medicine, San Diego, USA )
16 Jul 2025

Durvalumab and tremelimumab show manageable safety in poor-prognosis HCC

Prof Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong
Durvalumab and tremelimumab show manageable safety in poor-prognosis HCC ( Prof Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )
11 Jul 2025

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer

Dr Thorsten Oliver Goetze - The University Cancer Center (UCT), Frankfurt, Germany
Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer ( Dr Thorsten Oliver Goetze - The University Cancer Center (UCT), Frankfurt, Germany )
1 Jun 2025